Evidence map›Paper›PMID 41464129›Full record

ArticleDiagnostics (Basel, Switzerland)2025

Post-Surgical Reassessment of Breast Cancer IHC: Concordance, Δ-Metrics, and Treatment-Relevant Reclassification.

Ramona Andreea Cioroianu, Michael Schenker, Tradian Ciprian Berisha, Virginia-Maria Rădulescu, George Ovidiu Cioroianu, Raluca Chirculescu, Ana Maria Petrescu, Mihaela Popescu, Anda Lorena Dijmărescu, Stelian Ștefăniță Mogoantă

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ramona Andreea CioroianuDoctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Michael SchenkerDepartment of Oncology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Tradian Ciprian BerishaDoctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Virginia-Maria RădulescuDepartment of Medical Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0001-9028-7583
George Ovidiu CioroianuDepartment of Physical Medicine and Rehabilitation, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Raluca ChirculescuDepartment of Pathology, Filantropia Clinical Hospital, 011132 Bucharest, Romania.
Ana Maria PetrescuDoctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Mihaela PopescuDepartment of Endocrinology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Anda Lorena DijmărescuDepartment of Obstetrics-Gynecology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Stelian Ștefăniță MogoantăDepartment of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarker conversionbreast neoplasmsclinical decision-makingcore needle biopsyHER2immunohistochemistryKi-67 antigenneoadjuvant therapysurgical specimens

Identifiers

PMID41464129
PMCPMC12731989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.